Gene: ZNF93
Official Full Name: zinc finger protein 93provided by HGNC
Gene Summary: Enables DNA-binding transcription repressor activity, RNA polymerase II-specific. Involved in transposable element silencing. Predicted to be located in nucleoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25588 | ZNF93 Knockout cell line (HEK293) | Human | ZNF93 | 1:3~1:6 | Negative | Online Inquiry |
ZNF93 Gene Knockout Cell Lines are genetically modified cell lines in which the ZNF93 gene has been precisely disrupted, allowing researchers to study its specific functions and contributions to cellular processes. ZNF93, a member of the zinc finger protein family, is implicated in various regulatory mechanisms, such as transcriptional control and chromatin remodeling. By creating a knockout version of this gene, scientists can investigate the biological roles it plays in oncology, neurobiology, and cellular signaling pathways.
These cell lines operate through the precise elimination of ZNF93 expression, leading to alterations in downstream gene expression and cellular behavior that can be thoroughly analyzed. Researchers commonly use techniques such as CRISPR-Cas9 gene editing to achieve this targeted disruption, which allows for improved specificity and reduced off-target effects. The resulting cell lines enable investigations into the effects of ZNF93 loss-of-function on cellular proliferation, differentiation, and responses to drug treatments, making them valuable tools for both fundamental and applied biological research.
The scientific importance of ZNF93 knockout cell lines extends to their utility in drug discovery, disease modeling, and functional genomics. In clinical settings, these cell lines can further support preclinical development by elucidating gene-disease relationships and providing a platform for testing potential therapeutic interventions. The advancements in understanding ZNF93's role in various pathologies underscore the necessity of these models in contemporary biomedical research.
Compared to traditional cell lines or non-targeted systems, ZNF93 knockout cell lines offer the unique advantage of providing clarity in genetic studies. They allow for clearer interpretation of data and decrease the complexity inherent in using wild-type cells, which may harbor variable expressions of ZNF93. This focused approach facilitates streamlined research processes and accelerates the path from experimental data to clinical applications.
For researchers and clinicians alike, ZNF93 Gene Knockout Cell Lines represent a critical resource for advancing knowledge and therapeutic strategies in complex biological systems. Our commitment to delivering high-quality, rigorously validated biological products reflects our expertise in the field, empowering researchers to achieve breakthroughs in gene function studies and potential therapeutic developments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.